| 000 | 01263 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513135142.0 | ||
| 264 | 0 | _c19980318 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)78355-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOtte, A | |
| 245 | 0 | 0 |
_aYttrium-90-labelled somatostatin-analogue for cancer treatment. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cFeb 1998 |
||
| 300 |
_a417-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuroendocrine Tumors _xchemistry |
| 650 | 0 | 4 |
_aOctreotide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Somatostatin _xanalysis |
| 650 | 0 | 4 |
_aYttrium Radioisotopes _xtherapeutic use |
| 700 | 1 | _aMueller-Brand, J | |
| 700 | 1 | _aDellas, S | |
| 700 | 1 | _aNitzsche, E U | |
| 700 | 1 | _aHerrmann, R | |
| 700 | 1 | _aMaecke, H R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 351 _gno. 9100 _gp. 417-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)78355-0 _zAvailable from publisher's website |
| 999 |
_c9450522 _d9450522 |
||